Literature DB >> 21803215

Neurologic manifestations of chronic methamphetamine abuse.

Daniel E Rusyniak1.   

Abstract

Methamphetamine abuse has reached epidemic proportions in the United States. The repetitive use of methamphetamine causes massive and sustained elevations in central monoamines. These elevations, particularly in dopamine, can cause changes in the function of the central nervous system that can manifest as a variety of neurologic disorders. This article focuses on these disorders, such as neurocognitive disorders and mental illness, including drug-induced psychosis; motor disorders, including the possible risk of Parkinson's disease, the development of choreoathetoid movements, and punding; and changes in the physical appearance of the methamphetamine users, including dental caries.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803215      PMCID: PMC3148451          DOI: 10.1016/j.ncl.2011.05.004

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  102 in total

1.  Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.

Authors:  Russell C Callaghan; James K Cunningham; Gautam Sajeev; Stephen J Kish
Journal:  Mov Disord       Date:  2010-10-30       Impact factor: 10.338

2.  Episodic memory: from mind to brain.

Authors:  Endel Tulving
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

3.  The effects of alcohol and drug abuse on the skin.

Authors:  Stephanie W Liu; Mary H Lien; Neil Alan Fenske
Journal:  Clin Dermatol       Date:  2010 Jul-Aug       Impact factor: 3.541

4.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

5.  History of the methamphetamine problem.

Authors:  M D Anglin; C Burke; B Perrochet; E Stamper; S Dawud-Noursi
Journal:  J Psychoactive Drugs       Date:  2000 Apr-Jun

6.  Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; Y S Ding; M Sedler; J Logan; D Franceschi; J Gatley; R Hitzemann; A Gifford; C Wong; N Pappas
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

7.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; M Leonido-Yee; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; J Logan; C Wong; E N Miller
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

Review 8.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

Review 9.  The clinical toxicology of metamfetamine.

Authors:  Leo J Schep; Robin J Slaughter; D Michael G Beasley
Journal:  Clin Toxicol (Phila)       Date:  2010-08       Impact factor: 4.467

10.  Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning.

Authors:  Suzette Glasner-Edwards; Larissa J Mooney; Patricia Marinelli-Casey; Maureen Hillhouse; Alfonso Ang; Richard Rawson
Journal:  Am J Addict       Date:  2010 Sep-Oct
View more
  34 in total

Review 1.  Medication-Induced Tardive Dyskinesia: A Review and Update.

Authors:  Elyse M Cornett; Matthew Novitch; Alan David Kaye; Vijay Kata; Adam M Kaye
Journal:  Ochsner J       Date:  2017

Review 2.  Synthetic cathinones ("bath salts").

Authors:  Matthew L Banks; Travis J Worst; Daniel E Rusyniak; Jon E Sprague
Journal:  J Emerg Med       Date:  2014-02-22       Impact factor: 1.484

3.  The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats.

Authors:  John J Widholm; Justin T Gass; Richard M Cleva; M Foster Olive
Journal:  J Addict Res Ther       Date:  2011-12-24

Review 4.  Substance of abuse and movement disorders: complex interactions and comorbidities.

Authors:  Andres Deik; Rachel Saunders-Pullman; Marta San Luciano
Journal:  Curr Drug Abuse Rev       Date:  2012-09

5.  Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator.

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Lauren E Hood; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2012-07-21       Impact factor: 4.530

Review 6.  Methamphetamine Use and Cardiovascular Disease.

Authors:  Christopher G Kevil; Nicholas E Goeders; Matthew D Woolard; Md Shenuarin Bhuiyan; Paari Dominic; Gopi K Kolluru; Connie L Arnold; James G Traylor; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-21       Impact factor: 8.311

7.  Prefrontal glutamate correlates of methamphetamine sensitization and preference.

Authors:  Kevin D Lominac; Sema G Quadir; Hannah M Barrett; Courtney L McKenna; Lisa M Schwartz; Paige N Ruiz; Melissa G Wroten; Rianne R Campbell; Bailey W Miller; John J Holloway; Katherine O Travis; Ganesh Rajasekar; Dan Maliniak; Andrew B Thompson; Lawrence E Urman; Tod E Kippin; Tamara J Phillips; Karen K Szumlinski
Journal:  Eur J Neurosci       Date:  2016-02-22       Impact factor: 3.386

8.  Influencing Antibody-Mediated Attenuation of Methamphetamine CNS Distribution through Vaccine Linker Design.

Authors:  Major Gooyit; Pedro O Miranda; Cody J Wenthur; Alex Ducime; Kim D Janda
Journal:  ACS Chem Neurosci       Date:  2016-12-16       Impact factor: 4.418

9.  Human Immunodeficiency Virus Type 1 and Methamphetamine-Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons.

Authors:  Carmen Teodorof-Diedrich; Stephen A Spector
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

10.  Methamphetamine Induces Apoptosis of Microglia via the Intrinsic Mitochondrial-Dependent Pathway.

Authors:  Anna V Sharikova; Elizabeth Quaye; Jun Yong Park; Maxwell C Maloney; Habben Desta; Ramkumar Thiyagarajan; Kenneth L Seldeen; Neil U Parikh; Parteet Sandhu; Alexander Khmaladze; Bruce R Troen; Stanley A Schwartz; Supriya D Mahajan
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.